# name
Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial

# metadata.dc.description.abstract[].value
Purpose or ObjectiveExtracranial  stereotactic  body  radiation  therapy  (SBRT)  allows   delivering   high   doses   per   fraction   with   high   accuracy  to  the  prostatic  gland  in  a  low  number  of  fractions.Dose escalation in normofractionaded radiation prostate  cancer  trials  showed  an  increased  toxicity.In order to evaluate the feasibility and toxicity of a regimen of  a  single  dose  hypofractionated  prostate  stereotactic  boost  a  phase  II  study  was  undertaken.  Self-reported quality of life (QOL) measures were also obtained in order to   better   define   the   possible   deleterious   effect   of   treatment.

# metadata.dc.relation.ispartof[].value
Radiotherapy and Oncology, 2019, vol. 133, p. S830-S831

# metadata.dc.rights[].value
cc by-nc-nd (c) Elsevier Ireland Ltd, 2019

# metadata.dc.source[].value
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

# metadata.dc.title[].value
Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial